Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia
There is an urgent need for new antimicrobials to treat the opportunistic Gram-negative Burkholderia cenocepacia, which represents a problematic challenge for cystic fibrosis patients. Recently, a benzothiadiazole derivative, C109, was shown to be effective against the infections caused by B. cenoce...
Main Authors: | Laurent R. Chiarelli, Viola Camilla Scoffone, Gabriele Trespidi, Giulia Barbieri, Olga Riabova, Natalia Monakhova, Alessio Porta, Giulia Manina, Giovanna Riccardi, Vadim Makarov, Silvia Buroni |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2020.00562/full |
Similar Items
-
Molecular Characterization of the <i>Burkholderia cenocepacia</i> <i>dcw</i> Operon and FtsZ Interactors as New Targets for Novel Antimicrobial Design
by: Gabriele Trespidi, et al.
Published: (2020-11-01) -
Burkholderia cenocepacia keratitis
by: Geeta Behera, et al.
Published: (2020-01-01) -
Investigating the Mechanism of Action of Diketopiperazines Inhibitors of the Burkholderia cenocepacia Quorum Sensing Synthase CepI: A Site-Directed Mutagenesis Study
by: Silvia Buroni, et al.
Published: (2018-07-01) -
Burkholderia cenocepacia Prophages—Prevalence, Chromosome Location and Major Genes Involved
by: Bartosz Roszniowski, et al.
Published: (2018-05-01) -
First cases of Burkholderia cenocepacia IIIA neonatal sepsis in Central African Republic
by: Thierry Frank, et al.
Published: (2020-08-01)